Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2018

Feb 27, 2018

34129_dirs_2018-02-27_803b7f00-bf25-49b2-a9d5-28da777ecf6b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-02-26

Reporting Person: Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-26 Common Stock F 11070 $23.46 Disposed 18930 Direct

Footnotes

F1: Represents shares of common stock withheld to pay taxes upon vesting of restricted stock units originally granted to the Reporting Person on 2/25/16. The number of shares withheld was determined on 2/26/18 based on the closing price of Company common stock on that day.